Patents by Inventor Pascal Vaconsin

Pascal Vaconsin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Effervescent formulation based on pyridoxal-5-phosphate
    Patent number: 10960015
    Abstract: Provided is a fast-dissolving effervescent pharmaceutical formulation of pyridoxal-5-phosphate, and to the use thereof in the treatment of neonatal epilepsy and also of metabolic disorders with a need for pyridoxal-5-phosphate.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: March 30, 2021
    Assignee: Assistance Publique-Hopitaux De Paris
    Inventors: Stéphane Auvin, Thomas Storme, Pascal Vaconsin, Vincent Boudy
  • EFFERVESCENT FORMULATION BASED ON PYRIDOXAL-5-PHOSPHATE
    Publication number: 20190183911
    Abstract: Provided is a fast-dissolving effervescent pharmaceutical formulation of pyridoxal-5-phosphate, and to the use thereof in the treatment of neonatal epilepsy and also of metabolic disorders with a need for pyridoxal-5-phosphate.
    Type: Application
    Filed: December 18, 2018
    Publication date: June 20, 2019
    Applicant: Assistance Publique-Hopitaux De Paris
    Inventors: Stéphane Auvin, Thomas Storme, Pascal Vaconsin, Vincent Boudy
  • Effervescent formulation based on pyridoxal-5-phosphate
    Patent number: 10195221
    Abstract: Provided is a fast-dissolving effervescent pharmaceutical formulation of pyridoxal-5-phosphate, and to the use thereof in the treatment of neonatal epilepsy and also of metabolic disorders with a need for pyridoxal-5-phosphate.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: February 5, 2019
    Assignee: Assistance Publique-Hopitaux de Paris
    Inventors: Stéphane Auvin, Thomas Storme, Pascal Vaconsin, Vincent Boudy
  • EFFERVESCENT FORMULATION BASED ON PYRIDOXAL-5-PHOSPHATE
    Publication number: 20180303854
    Abstract: Provided is a fast-dissolving effervescent pharmaceutical formulation of pyridoxal-5-phosphate, and to the use thereof in the treatment of neonatal epilepsy and also of metabolic disorders with a need for pyridoxal-5-phosphate.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 25, 2018
    Inventors: Stéphane Auvin, Thomas Storme, Pascal Vaconsin, Vincent Boudy